Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 194.48 million compared to CNY 197.85 million a year ago. Net income was CNY 44.45 million compared to CNY 40.73 million a year ago.

Basic earnings per share from continuing operations was CNY 0.1786 compared to CNY 0.1633 a year ago. Diluted earnings per share from continuing operations was CNY 0.1786 compared to CNY 0.1633 a year ago.